A detailed history of Pnc Financial Services Group, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 16,493 shares of ADMA stock, worth $304,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,493
Previous 129 12685.27%
Holding current value
$304,130
Previous $1,000 32800.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$11.21 - $20.03 $183,440 - $327,770
16,364 Added 12685.27%
16,493 $329,000
Q2 2024

Aug 09, 2024

BUY
$5.98 - $11.18 $568 - $1,062
95 Added 279.41%
129 $1,000
Q1 2024

May 10, 2024

BUY
$4.4 - $6.74 $39 - $60
9 Added 36.0%
34 $0
Q4 2023

Feb 09, 2024

BUY
$3.08 - $4.52 $77 - $112
25 New
25 $0
Q3 2021

Nov 05, 2021

SELL
$1.13 - $1.65 $1,807 - $2,640
-1,600 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$1.51 - $2.07 $2,416 - $3,311
1,600 New
1,600 $2,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.62B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.